Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Defining HLA mismatch acceptability of organ transplant donors for sensitized recipients has traditionally been based on serologically defined HLA antigens. Now, however, it is well accepted that HLA antibodies specifically recognize a wide range of epitopes present on HLA antigens and that molecularly defined high resolution alleles corresponding to the same low resolution antigen can possess different epitope repertoires. Hence, determination of HLA compatibility at the allele level represents a more accurate approach to identify suitable donors for sensitized patients. This approach would offer opportunities for increased transplant rates and improved long term graft survivals.

Original publication

DOI

10.1111/ajt.13167

Type

Journal article

Journal

Am J Transplant

Publication Date

04/2015

Volume

15

Pages

923 - 930

Keywords

Alloantibody, immunogenetics, major histocompatibility complex (MHC), panel reactive antibody (PRA), sensitization, Alleles, Autoantibodies, HLA Antigens, Histocompatibility Testing, Humans, Immune Tolerance, Tissue Donors, Transplantation Immunology